Eva Schaake focuses on different aspects of the multimodality treatment in non-small cell lung cancer (NSCLC) patients. NSCLC is a smoking related and aggressive disease that covers 80% of the lung cancer subtypes. With most patients being diagnosed with metastasized disease and a life expectancy of under a year, researchers are facing many challenges for treatment improvement.
E.E. Schaake, Multimodality Approach Towards Individualized Non-Small Cell Lung Cancer Treatment.
Prof. P. Baas
Prof. M. Verheij (NKI-AvL)
Dr H.M. Klomp (NKI-AvL)
Dr J.A. Burgers (NKI-AvL)
This event is open to the public.